The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors
The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors
复制标题
DOI:
10.1007/s002130100742
复制
发表时间:
2001-06-01
影响因子:
3.4
通讯作者:
Cussac, D
中科院分区:
文献类型:
--
作者:
Millan, MJ;Newman-Tancredi, A;Cussac, D
Rationale: The benzazepine and "selective" dopamine DI receptor antagonist, SCH23390 [(R)-(+)8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-benzazepine-7-ol], shows significant affinity at native serotonin (5-HT)(2C) receptors. Objectives: We examined its functional actions at cloned human (h)5-HT2C receptors (VSV isoform) stably expressed in CHO cells. Methods: Since 5-HT2C receptors are positively coupled to phospholipase C (PLC), their activation was determined by depletion of membrane-bound pools of pre-labelled [H-3]phosphotidylinositol ([H-3]PI). Results: SCH23390 showed high affinity (K-i, 9.3 nM) at h5-HT2C sites and depleted [H-3]PI with an EC50 of 2.6 nM. Its efficacy was equivalent to that of 5-HT. [H-3]PI depletion elicited by SCH23390 was concentration-dependently abolished by the selective 5-HT2C antagonist, SB242,084, with a K-B Of 0.55 nM. Further, in the presence of a fixed concentration of SB242,084 (10 nM), the concentration-response curve for SCH23390 was shifted to the right without loss of maximal effect, yielding a K-B of 0.57 nM. Conclusions: SCH23390 is a potent and high efficacy agonist at h5-HT2C receptors. Activation of 5-HT2C receptors by SCH23390 may contribute to its functional properties both in animals and in humans.